Sesen Bio Announces Positive Preliminary 12-Month Data from Registration Phase 3 VISTA Trial of Vicinium for Non-Muscle Invasive Bladder Cancer
Stock Information for Carisma Therapeutics Inc Com
Loading
Please wait while we load your information from QuoteMedia.